SK287633B6 - Spôsob výroby humánneho gamaglobulínu G a humánny gamaglobulín G s inaktivovanými vírusmi - Google Patents
Spôsob výroby humánneho gamaglobulínu G a humánny gamaglobulín G s inaktivovanými vírusmi Download PDFInfo
- Publication number
- SK287633B6 SK287633B6 SK58-2002A SK582002A SK287633B6 SK 287633 B6 SK287633 B6 SK 287633B6 SK 582002 A SK582002 A SK 582002A SK 287633 B6 SK287633 B6 SK 287633B6
- Authority
- SK
- Slovakia
- Prior art keywords
- solution
- globulin
- concentration
- peg
- human
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200100101A ES2184594B1 (es) | 2001-01-17 | 2001-01-17 | Procedimiento para la produccion de gammaglobulina g humana inactivada de virus. |
Publications (2)
Publication Number | Publication Date |
---|---|
SK582002A3 SK582002A3 (en) | 2002-10-08 |
SK287633B6 true SK287633B6 (sk) | 2011-04-05 |
Family
ID=8496419
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK58-2002A SK287633B6 (sk) | 2001-01-17 | 2002-01-11 | Spôsob výroby humánneho gamaglobulínu G a humánny gamaglobulín G s inaktivovanými vírusmi |
Country Status (14)
Country | Link |
---|---|
US (1) | US6875848B2 (hu) |
EP (1) | EP1225180B1 (hu) |
JP (1) | JP4070468B2 (hu) |
AR (1) | AR032242A1 (hu) |
AT (1) | ATE382631T1 (hu) |
CZ (1) | CZ300413B6 (hu) |
DE (1) | DE60224310T2 (hu) |
ES (2) | ES2184594B1 (hu) |
HK (1) | HK1048324B (hu) |
HU (1) | HU228252B1 (hu) |
MX (1) | MXPA02000639A (hu) |
PT (1) | PT1225180E (hu) |
SK (1) | SK287633B6 (hu) |
UY (1) | UY27126A1 (hu) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040033228A1 (en) | 2002-08-16 | 2004-02-19 | Hans-Juergen Krause | Formulation of human antibodies for treating TNF-alpha associated disorders |
ES2626268T3 (es) | 2002-09-11 | 2017-07-24 | Chugai Seiyaku Kabushiki Kaisha | Método de purificación de proteínas |
US20060051347A1 (en) | 2004-09-09 | 2006-03-09 | Winter Charles M | Process for concentration of antibodies and therapeutic products thereof |
AU2005229674B2 (en) * | 2004-11-18 | 2010-11-04 | Kedrion Melville Inc. | Low concentration solvent/detergent process of immuneglobulin with pre-treatment |
SG162788A1 (en) | 2005-06-14 | 2010-07-29 | Amgen Inc | Self-buffering protein formulations |
US7879332B2 (en) * | 2005-09-01 | 2011-02-01 | Plasma Technologies, Llc | Ultra-high yield intravenous immune globulin preparation |
US20070049732A1 (en) * | 2005-09-01 | 2007-03-01 | Zurlo Eugene J | Ultra-high yield intravenous immune globulin preparation |
US8293242B2 (en) * | 2005-09-01 | 2012-10-23 | Plasma Technologies, Llc | Ultra-high yield of alpha-1-anti-trypsin |
JP2008094722A (ja) * | 2006-10-05 | 2008-04-24 | Benesis Corp | 免疫グロブリン製剤の製造方法 |
US20080214795A1 (en) * | 2007-02-14 | 2008-09-04 | Amgen Inc. | Method of isolating antibodies by precipitation |
TWI532498B (zh) | 2008-03-17 | 2016-05-11 | 巴克斯特保健公司 | 供免疫球蛋白及玻尿酸酶之皮下投藥之用的組合及方法 |
NZ597809A (en) | 2009-08-06 | 2014-05-30 | Genentech Inc | Method to improve virus removal in protein purification |
AU2010296017C1 (en) | 2009-09-17 | 2013-09-19 | Takeda Pharmaceutical Company Limited | Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof |
JP5814951B2 (ja) * | 2010-03-10 | 2015-11-17 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 免疫グロブリン溶液を精製するための方法 |
WO2013023362A1 (zh) * | 2011-08-16 | 2013-02-21 | 深圳市卫武光明生物制品有限公司 | 静注巨细胞病毒人免疫球蛋白及其制备方法 |
ES2381828B1 (es) | 2012-03-20 | 2012-11-16 | Grifols, S.A. | PROCEDIMIENTO PARA OBTENER UNA COMPOSICION DE IgG MEDIANTE TRATAMIENTO TERMICO |
WO2015158776A1 (en) | 2014-04-15 | 2015-10-22 | Boehringer Ingelheim International Gmbh | Methods, apparatuses, and systems for continuously inactivating a virus during manufacture of a biological product |
MY172309A (en) | 2014-06-12 | 2019-11-21 | Biosyn Arzneimittel Gmbh | Preparation methods for a novel generation of biological safe klh products used for cancer treatment, for the development of conjugated therapeutic vaccines and as challenging agents |
ES2717709T3 (es) | 2014-06-12 | 2019-06-24 | Biosyn Arzneimittel Gmbh | Métodos de preparación para una generación novedosa de productos de KLH biológicamente seguros usados para el tratamiento de cáncer, para el desarrollo de vacunas terapéuticas conjugadas y como agentes de exposición |
JP6521351B2 (ja) | 2014-10-14 | 2019-05-29 | テックプロジェクトサービス株式会社 | ウィルス不活化およびサンプリング装置 |
PL3215528T3 (pl) | 2014-11-06 | 2020-01-31 | F.Hoffmann-La Roche Ag | Warianty regionu Fc ze zmodyfikowanym wiązaniem FcRn i sposoby stosowania |
PT3135687T (pt) | 2015-08-31 | 2019-05-21 | Inst Grifols S A | Método para preparação de imunoglobulinas |
CA3012694A1 (en) | 2016-02-03 | 2017-08-10 | Plasma Technologies, Llc | Methods for extracting proteins from a blood-based material |
US11407981B2 (en) | 2016-03-11 | 2022-08-09 | Boehringer Ingelheim International Gmbh | Methods for continuously inactivating a virus during manufacture of a protein |
KR102372105B1 (ko) * | 2016-09-26 | 2022-03-07 | 인스티투토 그리폴스, 에스.아. | 면역글로블린의 제조방법 |
MX2019004580A (es) | 2016-10-21 | 2019-08-12 | Amgen Inc | Formulaciones farmaceuticas y metodos para prepararlas. |
US10815270B1 (en) | 2019-09-20 | 2020-10-27 | Plasma Technologies, Llc | Compositions and methods for high efficiency protein precipitation |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4164495A (en) * | 1976-04-06 | 1979-08-14 | Nordisk Insulinlaboratorium | Method of recovering immunoglobulin using a polyol and an alkanoic acid |
US4374763A (en) * | 1979-09-17 | 1983-02-22 | Morishita Pharmaceutical Co., Ltd. | Method for producing gamma-globulin for use in intravenous administration and method for producing a pharmaceutical preparation thereof |
EP0116571B2 (en) * | 1982-08-30 | 1997-10-29 | BAXTER INTERNATIONAL INC. (a Delaware corporation) | Method for making gamma globulin-containing compositions |
US5234685A (en) * | 1983-03-16 | 1993-08-10 | Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte | Method of determining incompatibility-reaction-causing substances in blood products as well as a method of inactivating said incompatibility-reaction-causing substances |
JP2547556B2 (ja) * | 1987-02-06 | 1996-10-23 | 株式会社 ミドリ十字 | r−グロブリンの液状製剤 |
US5177194A (en) * | 1990-02-01 | 1993-01-05 | Baxter International, Inc. | Process for purifying immune serum globulins |
ES2129076T5 (es) * | 1993-12-27 | 2003-05-16 | Zlb Bioplasma Ag | Procedimiento para la preparacion de un concentrado de inmunoglobulina g anti-d y composicion farmaceutica que lo contiene. |
CA2232420A1 (en) * | 1997-03-19 | 1998-09-19 | The Green Cross Corporation | Immunoglobulin preparation and preparation process thereof |
IL121900A (en) * | 1997-10-07 | 2001-12-23 | Omrix Biopharmaceuticals Ltd | A method for the purification of immunoglobulins |
CN1149100C (zh) * | 1997-10-23 | 2004-05-12 | 三菱制药株式会社 | 可室温贮存的免疫球蛋白静脉注射制剂 |
UA64742C2 (uk) * | 1997-12-24 | 2004-03-15 | Альфа Терапевтик Корпорейшн | СПОСІБ ОДЕРЖАННЯ РОЗЧИНУ <font face="Symbol">g</font>-ГЛОБУЛІНУ, ПРИЗНАЧЕНОГО ДЛЯ ВНУТРІШНЬОВЕННОГО ВВЕДЕННЯ, І ПРОДУКТ, ЩО ОДЕРЖУЄТЬСЯ У ЦЕЙ СПОСІБ (ВАРІАНТИ) |
ES2527915T3 (es) * | 1998-06-09 | 2015-02-02 | Csl Behring Ag | Producto de inmunoglobulina G (IgG) líquido |
KR100501263B1 (ko) * | 1998-06-09 | 2005-07-18 | 스태튼스 세룸 인스티튜트 | 정맥 주사용 면역글로불린의 제조 방법 및 그 외의 면역글로불린 제품 |
US6441144B1 (en) * | 1999-05-20 | 2002-08-27 | Alpha Therapeutic Corporation | Method for repairing dual virally inactivated immune globulin for intravenous administration |
-
2001
- 2001-01-17 ES ES200100101A patent/ES2184594B1/es not_active Expired - Fee Related
-
2002
- 2002-01-10 HU HU0200103A patent/HU228252B1/hu unknown
- 2002-01-11 DE DE60224310T patent/DE60224310T2/de not_active Expired - Lifetime
- 2002-01-11 CZ CZ20020131A patent/CZ300413B6/cs not_active IP Right Cessation
- 2002-01-11 PT PT02380009T patent/PT1225180E/pt unknown
- 2002-01-11 EP EP02380009A patent/EP1225180B1/en not_active Expired - Lifetime
- 2002-01-11 ES ES02380009T patent/ES2295308T3/es not_active Expired - Lifetime
- 2002-01-11 AT AT02380009T patent/ATE382631T1/de active
- 2002-01-11 SK SK58-2002A patent/SK287633B6/sk not_active IP Right Cessation
- 2002-01-15 AR ARP020100114A patent/AR032242A1/es active IP Right Grant
- 2002-01-16 UY UY27126A patent/UY27126A1/es not_active IP Right Cessation
- 2002-01-17 JP JP2002009029A patent/JP4070468B2/ja not_active Expired - Lifetime
- 2002-01-17 US US10/052,324 patent/US6875848B2/en not_active Expired - Lifetime
- 2002-01-17 MX MXPA02000639A patent/MXPA02000639A/es active IP Right Grant
-
2003
- 2003-01-21 HK HK03100521.5A patent/HK1048324B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1225180A2 (en) | 2002-07-24 |
MXPA02000639A (es) | 2004-11-01 |
DE60224310T2 (de) | 2009-01-08 |
JP2003002896A (ja) | 2003-01-08 |
CZ2002131A3 (cs) | 2002-09-11 |
EP1225180A3 (en) | 2004-01-28 |
PT1225180E (pt) | 2008-03-18 |
ATE382631T1 (de) | 2008-01-15 |
US6875848B2 (en) | 2005-04-05 |
ES2184594A1 (es) | 2003-04-01 |
JP4070468B2 (ja) | 2008-04-02 |
HUP0200103A2 (hu) | 2003-08-28 |
US20020151688A1 (en) | 2002-10-17 |
ES2295308T3 (es) | 2008-04-16 |
HK1048324A1 (en) | 2003-03-28 |
SK582002A3 (en) | 2002-10-08 |
HU228252B1 (en) | 2013-02-28 |
DE60224310D1 (de) | 2008-02-14 |
UY27126A1 (es) | 2002-07-31 |
AR032242A1 (es) | 2003-10-29 |
EP1225180B1 (en) | 2008-01-02 |
CZ300413B6 (cs) | 2009-05-13 |
ES2184594B1 (es) | 2004-01-01 |
HU0200103D0 (en) | 2002-03-28 |
HK1048324B (zh) | 2008-02-22 |
HUP0200103A3 (en) | 2004-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK287633B6 (sk) | Spôsob výroby humánneho gamaglobulínu G a humánny gamaglobulín G s inaktivovanými vírusmi | |
KR100501263B1 (ko) | 정맥 주사용 면역글로불린의 제조 방법 및 그 외의 면역글로불린 제품 | |
KR20070009995A (ko) | 바이러스 안전성 면역글로불린을 제조하는 방법 | |
JP2002517516A (ja) | 静脈投与用免疫グロブリン及び他の免疫グロブリン生成物の製造法 | |
US20060177909A1 (en) | Preparation of immunoglobulin | |
JP6132839B2 (ja) | 多価免疫グロブリン濃縮物の製造方法 | |
RU2636049C2 (ru) | СПОСОБ ПОЛУЧЕНИЯ КОМПОЗИЦИИ IgG ПОСРЕДСТВОМ ТЕПЛОВОЙ ОБРАБОТКИ | |
US10358462B2 (en) | Method for the preparation of immunoglobulins | |
CN107880116B (zh) | 用于制备免疫球蛋白的方法 | |
AU2016231646B2 (en) | Method for the preparation of immunoglobulins | |
CZ20014456A3 (cs) | Způsob přípravy intravenózního immunoglobulinu a přípravku, který jej obsahuje | |
JP6370853B2 (ja) | 免疫グロブリンの調製方法 | |
US11884702B2 (en) | Systems and methods for process scale isolation of immunoglobulin G | |
KR102372105B1 (ko) | 면역글로블린의 제조방법 | |
CA2943328C (en) | Method for the preparation of immunoglobulins | |
RU2708394C2 (ru) | Способ получения иммуноглобулинов | |
TWI712612B (zh) | 製備免疫球蛋白溶液的方法 | |
NZ724670A (en) | Method for the preparation of immunoglobulins | |
NZ724670B2 (en) | Method for the preparation of immunoglobulins | |
BR102016022107A2 (pt) | Processo de preparação de imunoglobulinas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK4A | Patent expired |
Expiry date: 20220111 |